Error message

Deprecated function: Using ${var} in strings is deprecated, use {$var} instead in include_once() (line 1442 of includes/bootstrap.inc).
Deprecated function: Using ${var} in strings is deprecated, use {$var} instead in include_once() (line 1442 of includes/bootstrap.inc).
Deprecated function: Optional parameter $type declared before required parameter $nid is implicitly treated as a required parameter in include_once() (line 1442 of includes/bootstrap.inc).

A.57 EPC Industrial application

An invention shall be considered as susceptible of industrial application if it can be made or used in any kind of industry, including agriculture.

[ Art. 52 100 138 R. 29 30 42 ]

See decisions of the Enlarged Board of Appeal G 1/03, G 2/03, G 1/04, G 1/16 (Annex I).

Source: http://www.epo.org/law-practice/legal-texts/html/epc/2016/e/ar57.html

Date retrieved: 17 May 2021

48 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

X Chapter I Patentability

X A.52 EPC Patentable inventions

X A.100 EPC Grounds for opposition

X A.138 EPC Revocation of European patents

EPC Implementing Rules

X R.29 EPC The human body and its elements

X R.30 EPC Requirements of European patent applications relating to nucleotide and amino acid sequences

X R.42 EPC Content of the description

EPO Guidelines Foreword

X GL FOREWORD 2.1 Overview

EPO Guidelines - B Search

X GL B VIII 1 General remarks

EPO Guidelines - D Opposition and Limitation/Revocation Procedures

X GL D III 5 Grounds for opposition

X GL D IV 1.2.2.1 Deficiencies under Rule 77(1)

X GL D V 2.2 Examination of the grounds for opposition

X GL D V 3 Non‑patentability pursuant to Art. 52 to Art. 57

EPO Guidelines - E General Procedural Matters

X GL E VI 2 Late-filed submissions

X GL E VI 3 Observations by third parties

EPO Guidelines - F The European Patent Application

X GL F II 4.9 Industrial application

EPO Guidelines - G Patentability

X GL G III 1 General remarks

EPO Guidelines - H Amendments and Corrections

X GL H IV 4.4.3 Points to be disregarded

X GL H V 4.1 The subject-matter to be excluded is not disclosed in the application as originally filed (so-called undisclosed disclaimers)

EPO PCT GL - F (not assigned)

X GL-PCT FOREWORD 3.1 Annex I: EPC-PCT concordance table

Offical Journal of the EPO

X OJ EPO SE 3/2018, p2 - BOARDS OF APPEAL AND ENLARGED BOARD OF APPEAL CASE LAW 2017

X OJ EPO 2018, A70 - Decision of the Enlarged Board of Appeal dated 18 December 2017 – G 1/16

X OJ EPO SE 6/2017, p70 - D. Sufficiency of disclosure

X OJ EPO 2017, A86 - Notice from the European Patent Office dated 5 July 2017 concerning the filing and processing of third-party observations under Article 115 EPC

X OJ EPO 2017, A50 - Interlocutory decision of the Technical Board of Appeal 3.3.09 dated 17 October 2016 - T 437/14

X OJ EPO 2011, 542 - Decision of Technical Board of Appeal 3.3.02 dated 27 October 2010 T 1635/09

X OJ EPO 2010, 456 - Decision of the Enlarged Board of Appeal dated 19 February 2010 G 2/08

X OJ EPO 2009, 36 - Decision of Technical Board of Appeal 3.3.02 dated 22 April 2008 T 1319/04

Case Law Book: I Patentability

X CLR I D 9.1.1 Technical character of an invention

X CLR I E 1 Notion of "industrial application"

X CLR I E 1.1 Invention and industrial application

X CLR I E 2 Reproducibility and sufficiency of disclosure

Case Law Book: II Conditions to be met by an Application

X CLR II A 1.1 Purpose of claims under Article 84 EPC

X CLR II E 1.7.2.C Explanations in G 1/16

Case Law Book: III Amendments

X CLR III N 1 Introduction

Case Law Book: IV Divisional Applications

X CLR IV C 3.4.1 General

X CLR IV D 1 Limitation/revocation – Article 105a EPC- Article 105c EPC

Case Law of the Enlarged Board

X G 0001/03 (Disclaimer/PPG) of 8.4.2004

X G 0002/03 (Disclaimer/GENETIC SYSTEMS) of 8.4.2004

X G 0001/04 (Diagnostic methods) of 16.12.2005

X G 0002/12 () of 25.3.2015

X G 0002/13 () of 25.3.2015

X G 0001/16 (Disclaimer III) of 18.12.2017

General Case Law

X T 0601/05 (Anti-TNF alpha human monoclonal antibodies/BAYER III) of 2.12.2009

X T 0018/09 (Neutrokine/HUMAN GENOME SCIENCES) of 21.10.2009

X T 1109/10 (Hydroxylases/LEXICON) of 13.3.2014

X T 2134/10 (S. pneumoniae antigen/HUMAN GENOME SCIENCES) of 14.11.2013

X T 1581/12 (Outer membrane protein immunogen Neisseria/GLAXOSMITHKLINE) of 15.9.2016